tiprankstipranks

Mark Schoenberg Insider Profile

4 Followers
Mark Schoenberg, CMO at Urogen Pharma, holds 144.28K shares in Urogen Pharma (Ticker: URGN).
tipranks
Mark Schoenberg

Mark Schoenberg
Urogen Pharma (URGN)
CMO

Ranked #83,274 out of 97,983 Corporate Insiders

Profitable Transactions

0%
0 out of 4 Profitable Transactions

Average Return

-31.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
A breakdown of Mark Schoenberg's holdings

Insider Roles

Urogen Pharma
(URGN)
CMO
Roles that Mark Schoenberg holds in companies

Most Profitable Insider Trade

Stock:
Urogen Pharma
(URGN)
Rating:Informative Sell
Date:Mar 20, 2024 - Today
Return:-6.10%
The most profitable trade made by Mark Schoenberg

Mark Schoenberg's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Urogen Pharma
Jun 11, 2024
CMO
Uninformative Buy
63.40K
$2.29M
Success Rate for
URGN
0 out of 4 profitable transactions on
URGN
0%
Average Return for
URGN
Average return per transaction on
URGN
-31.65%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jun 06, 2019
Uninformative Buy
$24.50K
-
$35.05
Sep 06, 2019
Uninformative Buy
$23.68K
-
$33.92
Dec 05, 2019
Uninformative Buy
$22.15K
-
$31.69
Jan 28, 2020
Uninformative Buy
$15.56K
-
$30.08
Mar 04, 2020
Uninformative Buy
$20.56K
-
$29.50
List of latest transactions for each holding click on a transaction to see Mark Schoenberg's performance on stock

Mark Schoenberg insider profile FAQ

What is the percentage of profitable transactions made by Mark Schoenberg?
The percentage of profitable transactions made by Mark Schoenberg is 0%.
    What is the average return per transaction made by Mark Schoenberg?
    The average return per transaction made by Mark Schoenberg is -31.60%.
      What stocks does Mark Schoenberg hold?
      Mark Schoenberg holds: URGN stocks.
        What was Mark Schoenberg’s latest transaction?
        Mark Schoenberg latest transaction was an Uninformative Buy of $63.40K.
          What was Mark Schoenberg's most profitable transaction?
          Mark Schoenberg’s most profitable transaction was an Informative Sell of URGN stock on March 20, 2024. The return on the trade was -6.10%.
            What is Mark Schoenberg's role in Urogen Pharma?
            Mark Schoenberg's role in Urogen Pharma is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.